Thienopyridine Derivatives [orch, phsu]
Aspirin [orch, phsu]
PREVENT [phsu]
Stroke [dsyn]
Serious Event [qlco]
vascular [bpoc]
High Risk [qlco]
vascular [bpoc]
Patients [podg]
Aspirin [orch, phsu]
Study [mnob]
prescribed [hlca]
Antiplatelet agent [phsu]
PREVENT [phsu]
Serious Event [qlco]
vascular [bpoc]
Reducing [qlco]
Events [evnt]
High Risk [qlco]
vascular [bpoc]
Patients [podg]
Quarter [qnco]
Thienopyridine Derivatives [orch, phsu]
arrested [dsyn]
Platelet Activation [ortf]
Mechanism [ftcn]
SO [geoa]
effective [qlco]
objectives [inpr]
Effectiveness [qlco]
Safety [hcpp]
Thienopyridine Derivatives [orch, phsu]
Ticlopidine [orch, phsu]
clopidogrel [orch, phsu]
Aspirin [orch, phsu]
PREVENT [phsu]
Serious Event [qlco]
vascular [bpoc]
Stroke [dsyn]
Myocardial Infarction [dsyn]
vascular [bpoc]
Patients [podg]
High Risk [qlco]
Patients [podg]
Previous [tmco]
TIA [dsyn]
Ischaemic stroke [dsyn]
search [inpr]
strategy [menp]
Searched [acty]
Trial [resa]
Registers [inpr]
Stroke [dsyn]
Heart [bpoc]
Peripheral Vascular Diseases [dsyn]
Review Group [prog]
Last [qlco]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
Library [mnob, orgt]
Issue [fndg]
MEDLINE [inpr]
Searched [acty]
Reference [idcn]
List [cnce]
Relevant [qlco]
Papers [mnob]
contact [ftcn]
Researchers [prog]
Pharmaceutical Company [hcro]
sanofi [hcro]
Selection Criteria [qlco]
DOUBLE BLIND [resa]
Trial [resa]
Directly [qlco]
thienopyridine [orch, phsu]
Derivative [ftcn]
Aspirin [orch, phsu]
High Risk [qlco]
vascular [bpoc]
Patients [podg]
Data Collection [resa]
Authors [prog]
Extracted [topp]
Assessed [acty]
Trial [resa]
Quality [qlco]
Additional [ftcn]
Principal Investigator [prog]
Largest [qnco]
Trial [resa]
Main [qlco]
included [ftcn]
Trial [resa]
Involving [ftcn]
High Risk [qlco]
vascular [bpoc]
Patients [podg]
Trial [resa]
Quality [qlco]
Aspirin [orch, phsu]
Compared [acty]
Ticlopidine [orch, phsu]
Nine [qnco]
Trial [resa]
Patients [podg]
clopidogrel [orch, phsu]
Trial [resa]
Patients [podg]
Compared [acty]
Aspirin [orch, phsu]
Allocation [acty]
thienopyridine [orch, phsu]
statistically significant [qnco]
reduction [npop]
Serious Event [qlco]
vascular [bpoc]
Odds Ratio [qnco]
Avoidance [menp]
Serious Event [qlco]
vascular [bpoc]
Patients [podg]
treated [topp]
Wide [spco]
Includes [ftcn]
Negligible [qlco]
Additional [ftcn]
Benefit [qnco]
Compared [acty]
Aspirin [orch, phsu]
thienopyridines [orch, phsu]
Reduced [qlco]
gastrointestinal [spco]
adverse effects [ftcn]
thienopyridines [orch, phsu]
Increased [qnco]
Skin Rash [dsyn]
Diarrhea [sosy]
Ticlopidine [orch, phsu]
clopidogrel [orch, phsu]
Allocation [acty]
Ticlopidine [orch, phsu]
clopidogrel [orch, phsu]
Increased [qnco]
Neutropenia [fndg]
Patients [podg]
TIA [dsyn]
Ischaemic stroke [dsyn]
For [qlco]
Patients [podg]
Combined [qlco]
Authors [prog]
Conclusions [idcn]
Thienopyridine Derivatives [orch, phsu]
effective [qlco]
Aspirin [orch, phsu]
PREVENT [phsu]
Serious Event [qlco]
vascular [bpoc]
Patients [podg]
High Risk [qlco]
Possibly [qlco]
Somewhat [inpr]
size [spco]
Additional [ftcn]
Benefit [qnco]
Uncertain [idcn]
Negligible [qlco]
clopidogrel [orch, phsu]
Favorable [qlco]
adverse effects [ftcn]
Profile [lbpr]
Ticlopidine [orch, phsu]
SO [geoa]
thienopyridine [orch, phsu]
choice [inbe]
Alternative [cnce]
Aspirin [orch, phsu]
Patients [podg]
intolerant [ftcn]
Allergic [ftcn]
Aspirin [orch, phsu]
